48. Clinical benefit table: SLM‐10 versus Artz. Dichotomous outcome measures.

Study	Time	Treatment	Outcome	No. improved	No. of pts	Risk (%)	Risk difference	NNT
Kawabata 1993	1‐4 wk	E: SLM‐10	Pain in movement (number of patients improved)	59	82	72	‐9	11.1
		C: Artz		60	74	81
Kawabata 1993	1‐4 wk	E: SLM‐10	Pain when resting (number of patietns improved)	33	93	85	5	20
		C: Artz		33	41	80
Kawabata 1993	1‐4 wk	E: SLM‐10	Pressure pain (number of patients improved)	48	75	64	‐18	5.6
		C: Artz		54	66	82
Kawabata 1993	1‐4 wk	E: SLM‐10	Number of patients better/much better	56	82	68	‐4	25
		C: Artz		53	74	72